NURS 6521 Midterm Exam / NURS6521 Midterm
Exam (V1)(100 Q and A): Advanced
Pharmacology:WALDEN UNIVERSITY(NEW)(2022-
2023)(QUESTIONS WITH ANSWERS)
1. A nurse practitioner is teaching a patient about how medications move through the body.
Which statement accurately describes pharmacokinetics?
A. "Pharmacokinetics explains how the drug produces its therapeutic effects at the receptor
site."
B. "Pharmacokinetics describes how the body absorbs, distributes, metabolizes, and eliminates
a drug."
C. "Pharmacokinetics is the study of how drugs interact with bacteria."
D. "Pharmacokinetics focuses only on the elimination phase of drug action."
Correct Answer: B
Rationale: Pharmacokinetics is defined as what the body does to a drug, encompassing
absorption, distribution, metabolism, and excretion (ADME) . Option A describes
pharmacodynamics. Option C refers to antimicrobial mechanisms. Option D incorrectly limits
the scope to only one phase.
2. A patient is prescribed a medication that undergoes extensive first-pass metabolism. The
provider should anticipate which adjustment?
A. A lower oral dose compared to the IV dose
B. A higher oral dose compared to the IV dose
C. The oral and IV doses will be identical
D. The medication should only be given rectally
Correct Answer: B
Rationale: First-pass metabolism reduces the bioavailability of orally administered drugs
before they reach systemic circulation. To achieve therapeutic plasma levels comparable to IV
administration, oral doses must be higher . Option A is incorrect because lower oral doses
would be subtherapeutic. Option C ignores the significant first-pass effect. Option D is not the
standard approach unless specifically indicated.
3. Which route of administration completely avoids first-pass metabolism?
,A. Oral
B. Rectal (lower portion)
C. Intravenous
D. Enteral
Correct Answer: C
Rationale: Intravenous administration delivers drug directly into systemic circulation,
bypassing the gastrointestinal tract and hepatic portal circulation entirely, resulting in 100%
bioavailability . Oral and enteral routes undergo first-pass metabolism. Rectal administration
partially avoids first-pass, but not completely.
4. A drug has a half-life of 8 hours. Approximately how long will it take to reach steady-state
plasma concentration?
A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C
Rationale: Steady-state is achieved after approximately 4–5 half-lives. With a half-life of 8
hours, steady-state occurs at 8 × 4 = 32 hours . Option A represents one half-life. Option B
represents two half-lives. Option D would be eight half-lives, which is unnecessarily long.
5. A patient with chronic kidney disease is prescribed a medication that is primarily
eliminated renally. The provider should anticipate which dosage adjustment?
A. Increase the dose to overcome reduced clearance
B. Shorten the dosing interval
C. Reduce the dose or extend the dosing interval
D. Administer the medication more frequently
Correct Answer: C
Rationale: Reduced renal function decreases drug clearance, leading to accumulation and
toxicity risk. The appropriate adjustment is to reduce the dose and/or extend the dosing
interval . Options A and D would worsen accumulation. Option B would also increase
accumulation risk.
6. Which statement best describes drug efficacy?
,A. The amount of drug required to produce 50% of maximal effect
B. The maximum therapeutic effect a drug can produce
C. The speed at which a drug is absorbed
D. The concentration of drug in plasma
Correct Answer: B
Rationale: Efficacy refers to the maximum therapeutic response a drug can produce,
regardless of dose . Option A describes potency (ED50). Option C describes absorption rate.
Option D describes plasma concentration, not efficacy.
7. A drug that binds to a receptor and activates a physiologic response is classified as:
A. An antagonist
B. A partial agonist
C. An agonist
D. An inverse agonist
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, producing a full physiologic
response . An antagonist blocks the receptor without activating it. A partial agonist produces a
submaximal response. An inverse agonist produces the opposite effect of an agonist.
8. A patient taking warfarin (highly protein-bound) is started on sulfonamide therapy. The
patient develops an elevated INR. What mechanism best explains this interaction?
A. Sulfonamides increase warfarin absorption
B. Sulfonamides displace warfarin from protein binding sites
C. Sulfonamides induce warfarin metabolism
D. Sulfonamides decrease renal elimination of warfarin
Correct Answer: B
Rationale: When two highly protein-bound drugs compete for binding sites, one drug
(sulfonamide) displaces the other (warfarin), increasing the free active fraction and enhancing
anticoagulant effect . Options A, C, and D describe mechanisms not primarily involved in this
interaction.
9. A patient with a history of angioedema is prescribed lisinopril. The patient develops lip and
tongue swelling. The provider should recognize this as:
A. An expected therapeutic effect
B. A serious adverse drug reaction requiring discontinuation
, C. Evidence of drug tolerance
D. A minor allergic response requiring antihistamines only
Correct Answer: B
Rationale: ACE inhibitors can cause angioedema, a potentially life-threatening adverse
reaction. Immediate discontinuation and medical evaluation are required . Option A is incorrect
because angioedema is never therapeutic. Option C is unrelated. Option D underestimates the
severity of ACE inhibitor-induced angioedema.
10. Which medication requires routine serum drug level monitoring due to its narrow
therapeutic index?
A. Acetaminophen
B. Lithium
C. Amoxicillin
D. Loratadine
Correct Answer: B
Rationale: Lithium has a narrow therapeutic index and requires regular serum level
monitoring to prevent toxicity (target typically 0.6–1.2 mEq/L) . Acetaminophen, amoxicillin, and
loratadine do not routinely require serum level monitoring.
11. A nurse practitioner is reviewing hepatic enzyme induction. What effect should be
anticipated when a patient takes a drug that induces CYP450 enzymes?
A. Increased serum levels of substrate drugs
B. Decreased serum levels of substrate drugs
C. No change in substrate drug metabolism
D. Increased absorption of substrate drugs from the GI tract
Correct Answer: B
Rationale: Enzyme induction increases the rate of drug metabolism, leading to decreased
serum concentrations of substrate drugs and potentially reduced therapeutic effect . Options A
and D are incorrect. Option C ignores the significant impact of enzyme induction.
12. Which phase II biotransformation reaction involves the addition of a methyl group?
A. Glucuronidation
B. Sulfation
C. Methylation
D. Acetylation
Exam (V1)(100 Q and A): Advanced
Pharmacology:WALDEN UNIVERSITY(NEW)(2022-
2023)(QUESTIONS WITH ANSWERS)
1. A nurse practitioner is teaching a patient about how medications move through the body.
Which statement accurately describes pharmacokinetics?
A. "Pharmacokinetics explains how the drug produces its therapeutic effects at the receptor
site."
B. "Pharmacokinetics describes how the body absorbs, distributes, metabolizes, and eliminates
a drug."
C. "Pharmacokinetics is the study of how drugs interact with bacteria."
D. "Pharmacokinetics focuses only on the elimination phase of drug action."
Correct Answer: B
Rationale: Pharmacokinetics is defined as what the body does to a drug, encompassing
absorption, distribution, metabolism, and excretion (ADME) . Option A describes
pharmacodynamics. Option C refers to antimicrobial mechanisms. Option D incorrectly limits
the scope to only one phase.
2. A patient is prescribed a medication that undergoes extensive first-pass metabolism. The
provider should anticipate which adjustment?
A. A lower oral dose compared to the IV dose
B. A higher oral dose compared to the IV dose
C. The oral and IV doses will be identical
D. The medication should only be given rectally
Correct Answer: B
Rationale: First-pass metabolism reduces the bioavailability of orally administered drugs
before they reach systemic circulation. To achieve therapeutic plasma levels comparable to IV
administration, oral doses must be higher . Option A is incorrect because lower oral doses
would be subtherapeutic. Option C ignores the significant first-pass effect. Option D is not the
standard approach unless specifically indicated.
3. Which route of administration completely avoids first-pass metabolism?
,A. Oral
B. Rectal (lower portion)
C. Intravenous
D. Enteral
Correct Answer: C
Rationale: Intravenous administration delivers drug directly into systemic circulation,
bypassing the gastrointestinal tract and hepatic portal circulation entirely, resulting in 100%
bioavailability . Oral and enteral routes undergo first-pass metabolism. Rectal administration
partially avoids first-pass, but not completely.
4. A drug has a half-life of 8 hours. Approximately how long will it take to reach steady-state
plasma concentration?
A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C
Rationale: Steady-state is achieved after approximately 4–5 half-lives. With a half-life of 8
hours, steady-state occurs at 8 × 4 = 32 hours . Option A represents one half-life. Option B
represents two half-lives. Option D would be eight half-lives, which is unnecessarily long.
5. A patient with chronic kidney disease is prescribed a medication that is primarily
eliminated renally. The provider should anticipate which dosage adjustment?
A. Increase the dose to overcome reduced clearance
B. Shorten the dosing interval
C. Reduce the dose or extend the dosing interval
D. Administer the medication more frequently
Correct Answer: C
Rationale: Reduced renal function decreases drug clearance, leading to accumulation and
toxicity risk. The appropriate adjustment is to reduce the dose and/or extend the dosing
interval . Options A and D would worsen accumulation. Option B would also increase
accumulation risk.
6. Which statement best describes drug efficacy?
,A. The amount of drug required to produce 50% of maximal effect
B. The maximum therapeutic effect a drug can produce
C. The speed at which a drug is absorbed
D. The concentration of drug in plasma
Correct Answer: B
Rationale: Efficacy refers to the maximum therapeutic response a drug can produce,
regardless of dose . Option A describes potency (ED50). Option C describes absorption rate.
Option D describes plasma concentration, not efficacy.
7. A drug that binds to a receptor and activates a physiologic response is classified as:
A. An antagonist
B. A partial agonist
C. An agonist
D. An inverse agonist
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, producing a full physiologic
response . An antagonist blocks the receptor without activating it. A partial agonist produces a
submaximal response. An inverse agonist produces the opposite effect of an agonist.
8. A patient taking warfarin (highly protein-bound) is started on sulfonamide therapy. The
patient develops an elevated INR. What mechanism best explains this interaction?
A. Sulfonamides increase warfarin absorption
B. Sulfonamides displace warfarin from protein binding sites
C. Sulfonamides induce warfarin metabolism
D. Sulfonamides decrease renal elimination of warfarin
Correct Answer: B
Rationale: When two highly protein-bound drugs compete for binding sites, one drug
(sulfonamide) displaces the other (warfarin), increasing the free active fraction and enhancing
anticoagulant effect . Options A, C, and D describe mechanisms not primarily involved in this
interaction.
9. A patient with a history of angioedema is prescribed lisinopril. The patient develops lip and
tongue swelling. The provider should recognize this as:
A. An expected therapeutic effect
B. A serious adverse drug reaction requiring discontinuation
, C. Evidence of drug tolerance
D. A minor allergic response requiring antihistamines only
Correct Answer: B
Rationale: ACE inhibitors can cause angioedema, a potentially life-threatening adverse
reaction. Immediate discontinuation and medical evaluation are required . Option A is incorrect
because angioedema is never therapeutic. Option C is unrelated. Option D underestimates the
severity of ACE inhibitor-induced angioedema.
10. Which medication requires routine serum drug level monitoring due to its narrow
therapeutic index?
A. Acetaminophen
B. Lithium
C. Amoxicillin
D. Loratadine
Correct Answer: B
Rationale: Lithium has a narrow therapeutic index and requires regular serum level
monitoring to prevent toxicity (target typically 0.6–1.2 mEq/L) . Acetaminophen, amoxicillin, and
loratadine do not routinely require serum level monitoring.
11. A nurse practitioner is reviewing hepatic enzyme induction. What effect should be
anticipated when a patient takes a drug that induces CYP450 enzymes?
A. Increased serum levels of substrate drugs
B. Decreased serum levels of substrate drugs
C. No change in substrate drug metabolism
D. Increased absorption of substrate drugs from the GI tract
Correct Answer: B
Rationale: Enzyme induction increases the rate of drug metabolism, leading to decreased
serum concentrations of substrate drugs and potentially reduced therapeutic effect . Options A
and D are incorrect. Option C ignores the significant impact of enzyme induction.
12. Which phase II biotransformation reaction involves the addition of a methyl group?
A. Glucuronidation
B. Sulfation
C. Methylation
D. Acetylation
